Provider

The roll out of a controversial smartphone app in Birmingham — the UK’s second largest city — is still being blocked this week despite the publication of a report that shows that the software “advances equality of access to GP services.

Patient-mediated exchange has been championed more and more recently as one potential answer to the long-vexing problem of interoperability.

Insurers have historically looked at claims data to determine a member's health needs.

A recent small study published in Nature’s Translational Psychiatry journal observed a change in the brain networking and behavior of boys receiving a video game-based treatment for ADHD.

ReMix, a new technology in the works at MIT's Computer Science and Artificial Intelligence Laboratory, seeks to make progress toward a new paradigm of treatment – one that's less reliant on endoscopy and surgery, but instead relies on sensors and what scientists call an "in-body GPS" to help make diagnoses and guide drug administration.

The Facebook-affliated research group partners with universities to study machine learning and artificial intelligence.

Deborah Kilpatrick has spent some time on the cutting edge of the healthcare industry — her decade-spanning career has included a director position at Guidant Corporation’s vascular intervention accelerator (now part of Boston Scientific) and the chief commercial officer role at genomic diagnostic company CardioDx.

A new tele-pharmacy 'super-hub' is set to help people living with chronic conditions and create 30 new jobs in Liverpool.

Healthy Interactions, a population health company that offers both digital and in-person programs for chronic disease management and education, and Merck have launched a diabetes management and engagement platform designed to support in-person counseling programs.

A recent study published in JAMA Surgery found that when it comes to reporting conflicts of interest in regards to compensation from medical device companies, doctors aren’t always completely forthcoming.